Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Orchid Pharma Plunges 5%; BSE HEALTHCARE Index Down 0.5%
Mon, 2 Sep 13:6

Orchid Pharma Plunges 5%; BSE HEALTHCARE Index Down 0.5%Image source: CreativaImages/www.istockphoto.com

Orchid Pharma share price has plunged 5% and is presently trading at Rs 1,442.0.

Meanwhile, the BSE HEALTHCARE index is at 42,941.3 (down 0.5%).

Among the top losers in the BSE HEALTHCARE index today are GRANULES INDIA (down 4.1%) and Dr. Reddys (down 2.6%).

Pfizer (up 4.5%) and MAX HEALTHCARE INSTITUTE (up 1.7%) are among the top gainers today.

Over the last one year, Orchid Pharma has moved up from Rs 549.1 to Rs 1,442.0, registering a gain of Rs 893.0 (up 162.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,815.8 to 42,941.3, registering a gain of 54.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 128.2%), Glenmark Pharma (up 124.1%) and SUVEN PHARMACEUTICALS (up 112.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 82,455.4 (up 0.1%).

The top gainers among the BSE Sensex today are Bajaj Finserv (up 3.4%) and HCl Tech. (up 3.0%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.

In the meantime, NSE Nifty is at 25,256.5 (up 0.1%). Bajaj Finserv and HCl Tech. are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,075.8 to 82,455.4, registering a gain of 17,379.6 points (up 26.7%).

Orchid Pharma Financial Update...

Orchid Pharma net profit grew 162.4% YoY to Rs 283 million for the quarter ended June 2024, compared to a profit of Rs 108 million a year ago. Net sales rose 33.6% to Rs 2,444 million during the period as against Rs 1,829 million in April-June 2023.

For the year ended March 2024, Orchid Pharma reported 72.1% increase in net profit to Rs 951 million compared to net profit of Rs 552 million during FY23. Revenue of the company grew 23.0% to Rs 8,194 million during FY24.

The current Price to earnings ratio of Orchid Pharma, based on rolling 12 month earnings, stands at 65.3.


Equitymaster requests your view! Post a comment on "Orchid Pharma Plunges 5%; BSE HEALTHCARE Index Down 0.5%". Click here!